Dr Yoshimitsu Soga (Kokura Memorial Hospital, Fukuoka, JP) discusses the 6-month results from the Lutonix® SFA Japan postmarket study (PMS), which aims to confirm the safety and efficacy of the Lutonix® 035 drug-coated PTA dilation catheter in a heterogeneous population. Questions:
1. Why was this study needed?
2. Can you describe the study design?
3. What data are you presenting at LINC 2020?
4. How should the results from this trial influence clinical practice?
5. What further research should be conducted with this device?
Filmed on location at the Leipzig Interventional Course 2020.
Interviewer: Ashlynne Merrifield
Videographer: Natascha Wienand
Музыка
Фильмы
ТВ Шоу
Категории видео
